Analgesic Efficacy of Morphine Alone or Combined With Paracetamol and/or Ibuprofen for Long-bones Fractures in Children (MORPHAPAIN)
Primary Purpose
Pain, Long-bone Fractures
Status
Completed
Phase
Phase 3
Locations
France
Study Type
Interventional
Intervention
Paracetamol
Ibuprofen
paracetamol + ibuprofen
Placebo
Sponsored by
About this trial
This is an interventional treatment trial for Pain focused on measuring Paediatric emergency, pain, long-bones fractures, morphine, ibuprofen, paracetamol, children
Eligibility Criteria
Inclusion Criteria:
- children aged 2 through 17 years (17 years included)
- suspected fracture of a long bone requiring morphine analgesia (VAS ≥ 60/100 or Evendol ≥ 7/15 at the arrival at emergency department)
- within the first 12 hours after the injury
- at least one signed parental informed consent
- affiliated to health insurance
Exclusion Criteria:
- analgesic treatment within the 6 hours before inclusion
- contraindication to one of the experimental drug: Paracetamol or Ibuprofen
- contraindication to Morphine
- cognitive impairment
- multiple injuries
- resuscitation manœuvres
- suspected femur fracture
- open fracture
- pregnant women in the third trimester
Sites / Locations
- Paediatric emergency Armand Trousseau hospital
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Arm Type
Experimental
Experimental
Experimental
Placebo Comparator
Arm Label
Ibuprofen+placebo of paracetamol
Paracetamol + placebo of ibuprofen
Paracetamol + ibuprofen
Placebo of paracetamol + placebo of ibuprofen
Arm Description
Patients will receive in addition to morphine (usual care) ibuprofen and placebo of paracetamol
Patients will receive in addition to morphine (usual care) paracetamol and placebo of ibuprofen
Patients will receive in addition to morphine (usual care) paracetamol and ibuprofen
Patients will receive morphine alone(usual care).
Outcomes
Primary Outcome Measures
Degree of pain measured by the EVENDOL score
To evaluate the degree of pain for children between 2 years and 6 years included : Evendol scale is a validated pain scale for use in the accident and emergency departments on children under 7 years old. Success: children 2-6 years (6 years included) with a pain score Evendol < 5 without additional analgesic treatment at 30 minutes after drug administration (DA)
Degree of pain measured by the Visual Analog Scale
To evaluate the degree of pain for children between 7 years and 17 years included. Patients will be asked to rate their pain severity on a validated 100 mm horizontal or vertical visual analog scale (VAS) marked "no pain" and "most severe pain" at the low and high ends respectively. A standardized explanation will be given to participating children. Success: children 7-17 years with pain score assessed by Visual Analog Scale (VAS) ≤ 30, without additional analgesic treatment at 30 minutes after drug administration (DA)
Secondary Outcome Measures
Degree of pain measured by the EVENDOL score
To evaluate the degree of pain for children between 2 years and 6 years included : Evendol scale is a validated pain scale for use in the accident and emergency departments on children under 7 years old.
Degree of pain measured by the EVENDOL score
To evaluate the degree of pain for children between 2 years and 6 years included : Evendol scale is a validated pain scale for use in the accident and emergency departments on children under 7 years old.
Degree of pain measured by the EVENDOL score
To evaluate the degree of pain for children between 2 years and 6 years included : Evendol scale is a validated pain scale for use in the accident and emergency departments on children under 7 years old.
Degree of pain measured by the EVENDOL score
To evaluate the degree of pain for children between 2 years and 6 years included : Evendol scale is a validated pain scale for use in the accident and emergency departments on children under 7 years old.
Degree of pain measured by the EVENDOL score
To evaluate the degree of pain for children between 2 years and 6 years included : Evendol scale is a validated pain scale for use in the accident and emergency departments on children under 7 years old.
Degree of pain measured by the Visual Analog Scale
To evaluate the degree of pain for children between 7 years and 17 years included. Patients will be asked to rate their pain severity on a validated 100 mm horizontal or vertical visual analog scale (VAS) marked "no pain" and "most severe pain" at the low and high ends respectively. A standardized explanation will be given to participating children.
Degree of pain measured by the Visual Analog Scale
To evaluate the degree of pain for children between 7 years and 17 years included. Patients will be asked to rate their pain severity on a validated 100 mm horizontal or vertical visual analog scale (VAS) marked "no pain" and "most severe pain" at the low and high ends respectively. A standardized explanation will be given to participating children.
Degree of pain measured by the Visual Analog Scale
To evaluate the degree of pain for children between 7 years and 17 years included. Patients will be asked to rate their pain severity on a validated 100 mm horizontal or vertical visual analog scale (VAS) marked "no pain" and "most severe pain" at the low and high ends respectively. A standardized explanation will be given to participating children.
Degree of pain measured by the Visual Analog Scale
To evaluate the degree of pain for children between 7 years and 17 years included. Patients will be asked to rate their pain severity on a validated 100 mm horizontal or vertical visual analog scale (VAS) marked "no pain" and "most severe pain" at the low and high ends respectively. A standardized explanation will be given to participating children.
Degree of pain measured by the Visual Analog Scale
To evaluate the degree of pain for children between 7 years and 17 years included. Patients will be asked to rate their pain severity on a validated 100 mm horizontal or vertical visual analog scale (VAS) marked "no pain" and "most severe pain" at the low and high ends respectively. A standardized explanation will be given to participating children.
Tolerance of ibuprofen
occurrence of abdominal pain or diarrhea or nausea or vomiting or digestive bleeding or itching or rash.
Tolerance of ibuprofen
occurrence of abdominal pain or diarrhea or nausea or vomiting or digestive bleeding or itching or rash.
Tolerance of ibuprofen
occurrence of abdominal pain or diarrhea or nausea or vomiting or digestive bleeding or itching or rash.
Tolerance of ibuprofen
occurrence of abdominal pain or diarrhea or nausea or vomiting or digestive bleeding or itching or rash.
Tolerance of ibuprofen
occurrence of abdominal pain or diarrhea or nausea or vomiting or digestive bleeding or itching or rash.
Tolerance of paracetamol
Occurrence of rash or hives or itching or swelling
Tolerance of paracetamol
Occurrence of rash or hives or itching or swelling
Tolerance of paracetamol
Occurrence of rash or hives or itching or swelling
Tolerance of paracetamol
Occurrence of rash or hives or itching or swelling
Tolerance of paracetamol
Occurrence of rash or hives or itching or swelling
Tolerance of morphine
heart and respiratory rates,
Tolerance of morphine
heart and respiratory rates,
Tolerance of morphine
heart and respiratory rates,
Tolerance of morphine
heart and respiratory rates,
Tolerance of morphine
heart and respiratory rates,
Tolerance of morphine
oxygen saturation
Tolerance of morphine
oxygen saturation
Tolerance of morphine
oxygen saturation
Tolerance of morphine
oxygen saturation
Tolerance of morphine
oxygen saturation
Tolerance of morphine
occurrence of consciousness nausea and vomiting or pruritus or drowsiness or dizziness
Tolerance of morphine
occurrence of consciousness nausea and vomiting or pruritus or drowsiness or dizziness
Tolerance of morphine
occurrence of consciousness nausea and vomiting or pruritus or drowsiness or dizziness
Tolerance of morphine
occurrence of consciousness nausea and vomiting or pruritus or drowsiness or dizziness
Tolerance of morphine
occurrence of consciousness nausea and vomiting or pruritus or drowsiness or dizziness
Full Information
NCT ID
NCT02477007
First Posted
April 9, 2015
Last Updated
January 17, 2019
Sponsor
Assistance Publique - Hôpitaux de Paris
1. Study Identification
Unique Protocol Identification Number
NCT02477007
Brief Title
Analgesic Efficacy of Morphine Alone or Combined With Paracetamol and/or Ibuprofen for Long-bones Fractures in Children
Acronym
MORPHAPAIN
Official Title
Phase III Clinical Trial Studying Analgesic Efficacy of Morphine Alone or Combined With Paracetamol and/or Ibuprofen for Long-bones Fractures in Children
Study Type
Interventional
2. Study Status
Record Verification Date
January 2019
Overall Recruitment Status
Completed
Study Start Date
December 3, 2015 (Actual)
Primary Completion Date
November 21, 2018 (Actual)
Study Completion Date
November 21, 2018 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Assistance Publique - Hôpitaux de Paris
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The main objective of this study is to evaluate the efficacy of two drugs: paracetamol and ibuprofen in association with morphine, compared with morphine alone on analgesia in children seen in the emergency department for a long-bone fracture and also to study the potential synergic effect of the association paracetamol and ibuprofen.
Detailed Description
Long-bone fractures are a very common complain for visits in paediatric emergency departments. Since these fractures are often very painful, morphine is considered the cornerstone treatment in case of severe pain. Very few data are available concerning the assessment of analgesic treatment in this condition. In our previous study, less than 50% of patients with a limb fracture had a Visual Analog Scale (VAS) ≤ 30 mm after morphine administration. Thus, one study make the hypothesis that the use of a combination of morphine and/or paracetamol and/or NSAID could be an effective and safe option for the treatment of pain due to long bone fractures. We undertake to compare different combinations of paracetamol and ibuprofen with morphine to determine the efficacy and safety of these strategies in emergency department paediatric patients with acute traumatic limb pain.
The main objective of this study is to evaluate the efficacy of two drugs: paracetamol and ibuprofen in association with morphine, compared with morphine alone on analgesia in children seen in the emergency department for a long-bone fracture and also to study the potential synergic effect of the association paracetamol and ibuprofen.
Second objectives are
to compare the long term analgesic efficacy of 4 analgesic regimens a)ibuprofen/morphine, b)paracetamol/morphine, c)ibuprofen/paracetamol/morphine and d)morphine for long bone fracture management in the paediatric emergency department.
To assess the tolerance of these 4 regimens.
The study is considered as a success if children 2-6 years (6 years included) have a pain score Evendol < 5 and children 7-17 years (17 years included) have a pain score assessed by Visual Analog Scale (VAS) ≤ 30 without additional analgesic treatment 30 minutes after drug administration.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Pain, Long-bone Fractures
Keywords
Paediatric emergency, pain, long-bones fractures, morphine, ibuprofen, paracetamol, children
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Factorial Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
304 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Ibuprofen+placebo of paracetamol
Arm Type
Experimental
Arm Description
Patients will receive in addition to morphine (usual care) ibuprofen and placebo of paracetamol
Arm Title
Paracetamol + placebo of ibuprofen
Arm Type
Experimental
Arm Description
Patients will receive in addition to morphine (usual care) paracetamol and placebo of ibuprofen
Arm Title
Paracetamol + ibuprofen
Arm Type
Experimental
Arm Description
Patients will receive in addition to morphine (usual care) paracetamol and ibuprofen
Arm Title
Placebo of paracetamol + placebo of ibuprofen
Arm Type
Placebo Comparator
Arm Description
Patients will receive morphine alone(usual care).
Intervention Type
Drug
Intervention Name(s)
Paracetamol
Intervention Description
Paracetamol will be an oral solution of 30 mg/ml. The doses of paracetamol will be 15 mg/kg (maximum dose: 1g).
Intervention Type
Drug
Intervention Name(s)
Ibuprofen
Intervention Description
Ibuprofen will be an oral suspension of 20mg/ml. The doses of ibuprofen 10 mg/kg (maximum dose: 400 mg).
Intervention Type
Drug
Intervention Name(s)
paracetamol + ibuprofen
Intervention Description
Paracetamol will be an oral solution of 30 mg/ml. The doses of paracetamol will be 15 mg/kg (maximum dose: 1g) Ibuprofen will be an oral suspension of 20mg/ml. The doses of ibuprofen 10 mg/kg (maximum dose: 400 mg).
Intervention Type
Drug
Intervention Name(s)
Placebo
Intervention Description
Placebo will have the closest flavour, smell and aspect to the active substances, respectively paracetamol and ibuprofen. Placebo will be prepared in bottles with a fake label of active substances for a better blinding both for the nurse and the patient. Labels will be hiding by a mask.
Primary Outcome Measure Information:
Title
Degree of pain measured by the EVENDOL score
Description
To evaluate the degree of pain for children between 2 years and 6 years included : Evendol scale is a validated pain scale for use in the accident and emergency departments on children under 7 years old. Success: children 2-6 years (6 years included) with a pain score Evendol < 5 without additional analgesic treatment at 30 minutes after drug administration (DA)
Time Frame
30 minutes
Title
Degree of pain measured by the Visual Analog Scale
Description
To evaluate the degree of pain for children between 7 years and 17 years included. Patients will be asked to rate their pain severity on a validated 100 mm horizontal or vertical visual analog scale (VAS) marked "no pain" and "most severe pain" at the low and high ends respectively. A standardized explanation will be given to participating children. Success: children 7-17 years with pain score assessed by Visual Analog Scale (VAS) ≤ 30, without additional analgesic treatment at 30 minutes after drug administration (DA)
Time Frame
30 minutes
Secondary Outcome Measure Information:
Title
Degree of pain measured by the EVENDOL score
Description
To evaluate the degree of pain for children between 2 years and 6 years included : Evendol scale is a validated pain scale for use in the accident and emergency departments on children under 7 years old.
Time Frame
after immobilisation
Title
Degree of pain measured by the EVENDOL score
Description
To evaluate the degree of pain for children between 2 years and 6 years included : Evendol scale is a validated pain scale for use in the accident and emergency departments on children under 7 years old.
Time Frame
15 minutes
Title
Degree of pain measured by the EVENDOL score
Description
To evaluate the degree of pain for children between 2 years and 6 years included : Evendol scale is a validated pain scale for use in the accident and emergency departments on children under 7 years old.
Time Frame
60 minutes
Title
Degree of pain measured by the EVENDOL score
Description
To evaluate the degree of pain for children between 2 years and 6 years included : Evendol scale is a validated pain scale for use in the accident and emergency departments on children under 7 years old.
Time Frame
90 minutes
Title
Degree of pain measured by the EVENDOL score
Description
To evaluate the degree of pain for children between 2 years and 6 years included : Evendol scale is a validated pain scale for use in the accident and emergency departments on children under 7 years old.
Time Frame
120 minutes
Title
Degree of pain measured by the Visual Analog Scale
Description
To evaluate the degree of pain for children between 7 years and 17 years included. Patients will be asked to rate their pain severity on a validated 100 mm horizontal or vertical visual analog scale (VAS) marked "no pain" and "most severe pain" at the low and high ends respectively. A standardized explanation will be given to participating children.
Time Frame
after immobilisation
Title
Degree of pain measured by the Visual Analog Scale
Description
To evaluate the degree of pain for children between 7 years and 17 years included. Patients will be asked to rate their pain severity on a validated 100 mm horizontal or vertical visual analog scale (VAS) marked "no pain" and "most severe pain" at the low and high ends respectively. A standardized explanation will be given to participating children.
Time Frame
15 minutes
Title
Degree of pain measured by the Visual Analog Scale
Description
To evaluate the degree of pain for children between 7 years and 17 years included. Patients will be asked to rate their pain severity on a validated 100 mm horizontal or vertical visual analog scale (VAS) marked "no pain" and "most severe pain" at the low and high ends respectively. A standardized explanation will be given to participating children.
Time Frame
60 minutes
Title
Degree of pain measured by the Visual Analog Scale
Description
To evaluate the degree of pain for children between 7 years and 17 years included. Patients will be asked to rate their pain severity on a validated 100 mm horizontal or vertical visual analog scale (VAS) marked "no pain" and "most severe pain" at the low and high ends respectively. A standardized explanation will be given to participating children.
Time Frame
90 minutes
Title
Degree of pain measured by the Visual Analog Scale
Description
To evaluate the degree of pain for children between 7 years and 17 years included. Patients will be asked to rate their pain severity on a validated 100 mm horizontal or vertical visual analog scale (VAS) marked "no pain" and "most severe pain" at the low and high ends respectively. A standardized explanation will be given to participating children.
Time Frame
120 minutes
Title
Tolerance of ibuprofen
Description
occurrence of abdominal pain or diarrhea or nausea or vomiting or digestive bleeding or itching or rash.
Time Frame
15 minutes
Title
Tolerance of ibuprofen
Description
occurrence of abdominal pain or diarrhea or nausea or vomiting or digestive bleeding or itching or rash.
Time Frame
30 minutes
Title
Tolerance of ibuprofen
Description
occurrence of abdominal pain or diarrhea or nausea or vomiting or digestive bleeding or itching or rash.
Time Frame
60 minutes
Title
Tolerance of ibuprofen
Description
occurrence of abdominal pain or diarrhea or nausea or vomiting or digestive bleeding or itching or rash.
Time Frame
90 minutes
Title
Tolerance of ibuprofen
Description
occurrence of abdominal pain or diarrhea or nausea or vomiting or digestive bleeding or itching or rash.
Time Frame
120 minutes
Title
Tolerance of paracetamol
Description
Occurrence of rash or hives or itching or swelling
Time Frame
15 minutes
Title
Tolerance of paracetamol
Description
Occurrence of rash or hives or itching or swelling
Time Frame
30 minutes
Title
Tolerance of paracetamol
Description
Occurrence of rash or hives or itching or swelling
Time Frame
60 minutes
Title
Tolerance of paracetamol
Description
Occurrence of rash or hives or itching or swelling
Time Frame
90 minutes
Title
Tolerance of paracetamol
Description
Occurrence of rash or hives or itching or swelling
Time Frame
120 minutes
Title
Tolerance of morphine
Description
heart and respiratory rates,
Time Frame
15 minutes
Title
Tolerance of morphine
Description
heart and respiratory rates,
Time Frame
30 minutes
Title
Tolerance of morphine
Description
heart and respiratory rates,
Time Frame
60 minutes
Title
Tolerance of morphine
Description
heart and respiratory rates,
Time Frame
90 minutes
Title
Tolerance of morphine
Description
heart and respiratory rates,
Time Frame
120 minutes
Title
Tolerance of morphine
Description
oxygen saturation
Time Frame
15 minutes
Title
Tolerance of morphine
Description
oxygen saturation
Time Frame
30 minutes
Title
Tolerance of morphine
Description
oxygen saturation
Time Frame
60 minutes
Title
Tolerance of morphine
Description
oxygen saturation
Time Frame
90 minutes
Title
Tolerance of morphine
Description
oxygen saturation
Time Frame
120 minutes
Title
Tolerance of morphine
Description
occurrence of consciousness nausea and vomiting or pruritus or drowsiness or dizziness
Time Frame
15 minutes
Title
Tolerance of morphine
Description
occurrence of consciousness nausea and vomiting or pruritus or drowsiness or dizziness
Time Frame
30 minutes
Title
Tolerance of morphine
Description
occurrence of consciousness nausea and vomiting or pruritus or drowsiness or dizziness
Time Frame
60 minutes
Title
Tolerance of morphine
Description
occurrence of consciousness nausea and vomiting or pruritus or drowsiness or dizziness
Time Frame
90 minutes
Title
Tolerance of morphine
Description
occurrence of consciousness nausea and vomiting or pruritus or drowsiness or dizziness
Time Frame
120 minutes
10. Eligibility
Sex
All
Minimum Age & Unit of Time
2 Years
Maximum Age & Unit of Time
17 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
children aged 2 through 17 years (17 years included)
suspected fracture of a long bone requiring morphine analgesia (VAS ≥ 60/100 or Evendol ≥ 7/15 at the arrival at emergency department)
within the first 12 hours after the injury
at least one signed parental informed consent
affiliated to health insurance
Exclusion Criteria:
analgesic treatment within the 6 hours before inclusion
contraindication to one of the experimental drug: Paracetamol or Ibuprofen
contraindication to Morphine
cognitive impairment
multiple injuries
resuscitation manœuvres
suspected femur fracture
open fracture
pregnant women in the third trimester
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Hélène Chappuy, MD PhD
Organizational Affiliation
Study Principal Investigator
Official's Role
Principal Investigator
Facility Information:
Facility Name
Paediatric emergency Armand Trousseau hospital
City
Paris
ZIP/Postal Code
75012
Country
France
12. IPD Sharing Statement
Plan to Share IPD
No
Citations:
PubMed Identifier
17332198
Citation
Clark E, Plint AC, Correll R, Gaboury I, Passi B. A randomized, controlled trial of acetaminophen, ibuprofen, and codeine for acute pain relief in children with musculoskeletal trauma. Pediatrics. 2007 Mar;119(3):460-7. doi: 10.1542/peds.2006-1347. Erratum In: Pediatrics. 2007 Jun;119(6):1271.
Results Reference
background
PubMed Identifier
17876251
Citation
Koller DM, Myers AB, Lorenz D, Godambe SA. Effectiveness of oxycodone, ibuprofen, or the combination in the initial management of orthopedic injury-related pain in children. Pediatr Emerg Care. 2007 Sep;23(9):627-33. doi: 10.1097/PEC.0b013e31814a6a39.
Results Reference
background
PubMed Identifier
10536549
Citation
Morton NS, O'Brien K. Analgesic efficacy of paracetamol and diclofenac in children receiving PCA morphine. Br J Anaesth. 1999 May;82(5):715-7. doi: 10.1093/bja/82.5.715.
Results Reference
background
Learn more about this trial
Analgesic Efficacy of Morphine Alone or Combined With Paracetamol and/or Ibuprofen for Long-bones Fractures in Children
We'll reach out to this number within 24 hrs